1-20 of 39
Sabine Cerny-Reiterer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases

Yashodhara Dasgupta, Mateusz Koptyra, Grazyna Hoser, Kanchan Kantekure, Darshan Roy, Barbara Gornicka, Margaret Nieborowska-Skorska, Elisabeth Bolton-Gillespie, Sabine Cerny-Reiterer, Markus Müschen, Peter Valent, Mariusz A. Wasik, Christine Richardson, Oliver Hantschel, Heiko van der Kuip, Tomasz Stoklosa, Tomasz Skorski
Journal: Blood
Blood (2016) 127 (17): 2131–2143.
https://doi.org/10.1182/blood-2015-11-681171
Published: 2016
Includes: Supplemental data
Journal Articles

Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis

Katharina Blatt, Sabine Cerny-Reiterer, Juliana Schwaab, Karl Sotlar, Gregor Eisenwort, Gabriele Stefanzl, Gregor Hoermann, Matthias Mayerhofer, Mathias Schneeweiss, Sylvia Knapp, Thomas Rülicke, Emir Hadzijusufovic, Karin Bauer, Dubravka Smiljkovic, Michael Willmann, Andreas Reiter, Hans-Peter Horny, Peter Valent
Journal: Blood
Blood (2015) 126 (26): 2832–2841.
https://doi.org/10.1182/blood-2015-03-637728
Published: 2015
Includes: Supplemental data
Journal Articles

Targeting of Quiescent and Proliferating CML Stem Cells By DNA Repair Inhibitors

Katherine Sullivan, Elisabeth Bolton-Gillespie, Margaret Nieborowska-Skorska, Sabine Cerny-Reiterer, DVM, Peter Valent, MD, Markus Muschen, MDPhD, Richard Pomerantz, Alexander Mazin, Tomasz Skorski
Journal: Blood
Blood (2015) 126 (23): 50.
https://doi.org/10.1182/blood.V126.23.50.50
Published: 2015
Journal Articles

Functional Analysis of the CML Blast Crisis Transcriptome and Epigenome Using Crispr-CAS9 and Pharmacologic Approaches

Tun Kiat Ko, PhD, Xin Xuan Sheila Soh, Willie Yu, PhD, Peter S. Winter, Thushangi Pathiraja, PhD, Asif Javed, PhD, Simeen Malik, PhD, Joanna H.J. Tan, Charles Chuah, MD PhD, Naoto Takahashi, MD, PhD, Ravi Bhatia, MD, Wee Joo Chng, MD PhD, Peter Valent, MD, Sabine Cerny-Reiterer, DVM, King Pan Ng, PhD, Chandana Tennakoon, PhD, Qiangze Hoi, Peiyong Guan, Audrey S.M. Teo, Wah Heng Lee, PhD, Patrick Tan, MD PhD, Win Kin Sung, PhD, Pauline Ng, PhD, Axel Hillmer, PhD, Kris C. Wood, PhD, Steve Rozen, PhD, S. Tiong Ong, MD
Journal: Blood
Blood (2015) 126 (23): 2764.
https://doi.org/10.1182/blood.V126.23.2764.2764
Published: 2015
Journal Articles

Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells

Margaret Nieborowska-Skorska, MD PhD, Katherine Sullivan, Paulina Podszywalow-Bartnicka, Grazyna Hoser, PhD, Elisabeth Bolton-Gillespie, Kimberly Cramer-Morales, Artur Slupianek, PhD, Chun Zhou, PhD, Sabine Cerny-Reiterer, DVM, Tomasz Stoklosa, MD PhD, Stephen M. Sykes, PhD, Peter Valent, MD, Curt I. Civin, MD, Markus Muschen, MD PhD, Mark D. Minden, MD PhD, Kolja Eppert, PhD, Tomasz Skorski, MD PhD
Journal: Blood
Blood (2014) 124 (21): 480.
https://doi.org/10.1182/blood.V124.21.480.480
Published: 2014
Journal Articles

Next Generation Sequencing Identifies DNA Methylation Patterns Indicative of Disease Progression in Ph + CML

Gerwin Heller, PhD, Thais Topakian, Corinna Altenberger, MSc, Sabine Cerny-Reiterer, Dr., Barbara Ziegler, Paul Datlinger, MSc, Christoph Bock, PhD, Christine Mannhalter, PhD, Gregor Hörmann, MD PhD, Wolfgang R Sperr, MD, Christoph C Zielinski, MD, Peter Valent, MD, Sabine Zöchbauer-Müller, MD
Journal: Blood
Blood (2014) 124 (21): 4526.
https://doi.org/10.1182/blood.V124.21.4526.4526
Published: 2014
Journal Articles

Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Emir Hadzijusufovic, DVM, Karin Albrecht-Schgoer, PhD, Kilian Huber, PhD, Florian Grebien, PhD, Gregor Eisenwort, MD PhD, Wilfried Schgoer, MD PhD, Christoph Kaun, Susanne Herndlhofer, Markus Theurl, PhD, Sabine Cerny-Reiterer, DVM, Gregor Hoermann, MD PhD, Wolfgang R Sperr, MD, Uwe Rix, PhD, Irina Sadovnik, MSc, Bernd Jilma, MD, Gerit Holger Schernthaner, MD, Johann Wojta, PhD, Dominik Wolf, MD, Giulio Superti-Furga, PhD, Rudolf Kirchmair, MD, Peter Valent, MD
Journal: Blood
Blood (2014) 124 (21): 1800.
https://doi.org/10.1182/blood.V124.21.1800.1800
Published: 2014
Journal Articles

Inactivation of the SETD2 Tumor Suppressor Gene in Mast Cell Leukemia

Simona Soverini, PhD, Caterina De Benedittis, Michela Rondoni, MD, Manuela Mancini, PhD, Cristina Papayannidis, MD PhD, Viviana Guadagnuolo, PhD, Elisa Leo, PhD, Luca Zazzeroni, Raffaele Calogero, PhD, Elisa Zago, Anna Scandola, Marianna Garonzi, Alberto Ferrarini, Paolo Savini, MD, Oliviero Quercia, Livio Pagano, MD, Roberta Zanotti, MD, Omar Perbellini, MD, Giorgina Specchia, Serena Merante, Chiara Elena, MD, Domenica Gangemi, Giovanni Poletti, MD, Massimo Delledonne, PhD, Sabine Cerny-Reiterer, Dr., Michele Cavo, MD, Peter Valent, MD, Giovanni Martinelli
Journal: Blood
Blood (2014) 124 (21): 1881.
https://doi.org/10.1182/blood.V124.21.1881.1881
Published: 2014
Journal Articles

Maintenance with Histamine and IL-2 Induces a Marked Expansion of Activated CD56 bright NK Cells in Acute Myeloid Leukemia

Angelica Cuapio, Dr. MD, Mirte Post, Sabine Cerny-Reiterer, Dr., Markus Osl, Volker Huppert, PhD, Karoline V Gleixner, MD, Susanne Herndlhofer, Wolfgang R Sperr, MD, Peter Valent, MD, Erhard Hofer, Dr.
Journal: Blood
Blood (2014) 124 (21): 1422.
https://doi.org/10.1182/blood.V124.21.1422.1422
Published: 2014
Journal Articles

Identification of a Neoplastic Stem Cell in Human Mast Cell Leukemia

Gregor Eisenwort, MD PhD, Barbara Peter, D.V.M., Katharina Blatt, MSc, PhD, Sabine Cerny-Reiterer, DVM, Gregor Hoermann, MD PhD, Irina Sadovnik, MSc, Martin Bilban, MD, Thomas Rülicke, D.V.M., Michael Willmann, D.V.M., Juliana Schwaab, MD, Andreas Reiter, MD, Wolfgang R Sperr, MD, Christine Mannhalter, PhD, Peter Valent, MD
Journal: Blood
Blood (2014) 124 (21): 817.
https://doi.org/10.1182/blood.V124.21.817.817
Published: 2014
Journal Articles

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection

Rosine Saleh, Ghaith Wedeh, Harald Herrmann, Siham Bibi, Sabine Cerny-Reiterer, Irina Sadovnik, Katharina Blatt, Emir Hadzijusufovic, Sylvie Jeanningros, Catherine Blanc, Magali Legarff-Tavernier, Elise Chapiro, Florence Nguyen-Khac, Frédéric Subra, Patrick Bonnemye, Patrice Dubreuil, Vanessa Desplat, Hélène Merle-Béral, Michael Willmann, Thomas Rülicke, Peter Valent, Michel Arock
Journal: Blood
Blood (2014) 124 (1): 111–120.
https://doi.org/10.1182/blood-2013-10-534685
Published: 2014
Includes: Supplemental data
Journal Articles

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Harald Herrmann, Irina Sadovnik, Sabine Cerny-Reiterer, Thomas Rülicke, Gabriele Stefanzl, Michael Willmann, Gregor Hoermann, Martin Bilban, Katharina Blatt, Susanne Herndlhofer, Matthias Mayerhofer, Berthold Streubel, Wolfgang R. Sperr, Tessa L. Holyoake, Christine Mannhalter, Peter Valent
Journal: Blood
Blood (2014) 123 (25): 3951–3962.
https://doi.org/10.1182/blood-2013-10-536078
Published: 2014
Includes: Supplemental data
Journal Articles

Bromodomain-Containing Protein 4 (BRD4): A Novel Marker and Drug Target Expressed In Neoplastic Cells In Advanced Mast Cell Neoplasms

Ghaith Wedeh, Emir Hadzijusufovic, DVM, Sabine Cerny-Reiterer, D.V.M, Harald Herrmann, M.D., Katharina Blatt, MSc, Ph.D., Gregor Eisenwort, M.D., Ph.D, Gregor Hoermann, M.D., Ph.D., Wolfgang R Sperr, M.D., Leonhard Müllauer, M.D., Christopher R. Vakoc, M.D., Ph.D., James E Bradner, MD, Hans-Peter Horny, MD, Michael Willmann, D.V.M., Johannes Zuber, MD, Michel Arock, PharmD, Ph.D, Peter Valent
Journal: Blood
Blood (2013) 122 (21): 3747.
https://doi.org/10.1182/blood.V122.21.3747.3747
Published: 2013
Journal Articles

Identification Of The Ki-1 Antigen (CD30) As a Novel Marker and Potential Therapeutic Target In Neoplastic Mast Cells In Advanced Systemic Mastocytosis

Katharina Blatt, MSc, Ph.D., Sabine Cerny-Reiterer, D.V.M, Karl Sotlar, M.D., Schwaab Juliana, M.D., Gregor Hoermann, M.D., Ph.D., Matthias Mayerhofer, M.D., Emir Hadzijusufovic, DVM, Michael Willmann, D.V.M., Andreas Reiter, MD, Hans-Peter Horny, MD, Peter Valent
Journal: Blood
Blood (2013) 122 (21): 3773.
https://doi.org/10.1182/blood.V122.21.3773.3773
Published: 2013
Journal Articles

Phenotyping Of Leukemic Stem Cells In Ph+ ALL and Ph- ALL Reveals Unique Profiles Of Markers and Targets In Distinct Disease Variants

Sabine Cerny-Reiterer, D.V.M, Katharina Blatt, MSc, Ph.D., Harald Herrmann, M.D., Gregor Eisenwort, M.D., Ph.D, Susanne Herndlhofer, Heinz Sill, M.D., Werner Rabitsch, MD, Christine Mannhalter, M.D., Alexander Hauswirth, M.D., Wolfgang R Sperr, M.D., Ulrich Jaeger, Peter Valent
Journal: Blood
Blood (2013) 122 (21): 1654.
https://doi.org/10.1182/blood.V122.21.1654.1654
Published: 2013
Journal Articles

Imatinib Inhibits SCF-Induced Development Of Human Mast Cells In Vitro and Induces Profound and Selective Mast Cell Deficiency In Patients With Ph+ CML

Sabine Cerny-Reiterer, D.V.M, Anja Rabenhorst, Msc, Ph.D., Gabriele Stefanzl, Msc, Susanne Herndlhofer, Katharina Blatt, MSc, Ph.D., Gregor Hoermann, M.D., Ph.D., Leonhard Muellauer, M.D., Sigrid Baumgartner, M.D., Christine Beham-Schmid, M.D., Wolfgang R Sperr, M.D., Werner Linkesch, M.D., Christine Mannhalter, M.D., Michel Arock, PharmD, Ph.D, Karin Hartmann, M.D., Peter Valent
Journal: Blood
Blood (2013) 122 (21): 3988.
https://doi.org/10.1182/blood.V122.21.3988.3988
Published: 2013
Journal Articles

The Oncogenic Transcription Factor STAT5 Triggers Aberrant Expression Of CD25 (IL-2RA) In Neoplastic Stem Cells In Ph + CML

Irina Sadovnik, M.Sc., Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M, Wolfgang Warsch, Ph.D., Andrea Hoelbl, Ph.D., Katharina Blatt, MSc, Ph.D., Barbara Peter, D.V.M., Gabriele Stefanzl, Msc, Gregor Hoermann, M.D., Ph.D., Susanne Herndlhofer, Berthold Streubel, M.D., Wolfgang R Sperr, M.D., Christine Mannhalter, Ph.D., Veronika Sexl, MD, Peter Valent
Journal: Blood
Blood (2013) 122 (21): 3979.
https://doi.org/10.1182/blood.V122.21.3979.3979
Published: 2013
Journal Articles

Oncogene-Induced DNA Repair Defects Promote PARP1-Mediated “Dual Synthetic Lethality” To Eradicate Quiescent and Proliferating Leukemia Stem and Progenitor Cells

Margaret Nieborowska-Skorska, MD, PhD, Artur Slupianek, PhD, Grazyna Hoser, PhD, Elisabeth Bolton-Gillespie, PhD, Alexei Tulin, Sabine Cerny-Reiterer, D.V.M, Peter Valent, Markus Muschen, Stephen M. Sykes, PhD, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 810.
https://doi.org/10.1182/blood.V122.21.810.810
Published: 2013
Journal Articles

Nilotinib Exerts Direct Pro-Atherogenic and Anti-Angiogenic Effects On Vascular Endothelial Cells: A Potential Explanation For Drug-Induced Vasculopathy In CML

Hadzijusufovic Emir, DVM, Karin Albrecht-Schgoer, PhD, Kilian Huber, PhD, Florian Grebien, PhD, Gregor Eisenwort, MD, PhD, Wilfried Schgoer, MD, PhD, Christoph Kaun, Susanne Herndlhofer, Markus Theurl, PhD, Sabine Cerny-Reiterer, D.V.M., Gregor Hoermann, M.D., Ph.D., Wolfgang R Sperr, M.D., Rix Uwe, PhD, Johann Wojta, PhD, Dominik Wolf, MD, Giulio Superti-Furga, PhD, Rudolf Kirchmair, MD, Peter Valent
Journal: Blood
Blood (2013) 122 (21): 257.
https://doi.org/10.1182/blood.V122.21.257.257
Published: 2013
Journal Articles

Identification of Campath-1 Antigen (CD52) As a Novel Therapeutic Target in Advanced Systemic Mastocytosis.

Gregor Hoermann, M.D., Ph.D., Katharina Blatt, MSc, Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M., Leonhard Müllauer, M.D., Peter Valent, MD, Matthias Mayerhofer, M.D.
Journal: Blood
Blood (2012) 120 (21): 2866.
https://doi.org/10.1182/blood.V120.21.2866.2866
Published: 2012